Please login to the form below
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July
Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.
He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.
“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.
Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.
Featured jobs
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Science Writer – Healthcare Advertising
-
Salary TBC
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Moving annual total (MAT)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- Key success factor (KSF)
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- 30 women leaders in UK healthcare (part 3)
- Part 3 of our list of thirty women leaders...
- 30 Women Leaders in UK Healthcare
- The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...
- 30 Women Leaders in UK Healthcare (part 2)
- Part two of our list of thirty women leaders 11-20...
Quick links
Infographics
